CYP3A4 and hepatocellular carcinoma: Among these DEGs, several top hits (SLC10A1, CYP3A4, SPP2, and LECT2) were also revealed to be negative glycolytic regulators in HCC by other group 31, indicating that our analysis was built on the meaningful context of aerobic glycolysis.